Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques

Jennifer E. Loomis-Huff, R. Eberle, Kristen M. Lockridge, Gary Rhodes, Peter A Barry

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Herpes B virus (Cercopithecine herpesvirus 1) is endemic in captive macaque populations and poses a serious threat to humans who work with macaques or their tissues. A vaccine that could prevent or limit B virus infection in macaques would lessen occupational risk. To that end, a DNA vaccine plasmid expressing the B virus glycoprotein B (gB) was constructed and tested for immunogenicity in mice and macaques. Intramuscular (IM) or intradermal (ID) immunization in mice elicited antibodies to gB that were relatively stable over time and predominately of the IgG2a isotype. Five juvenile macaques were immunized by either IM + ID (n = 2) or IM (n = 3) routes, with two booster immunizations at 10 and 30 weeks. All five animals developed antibodies to B virus gB, with detectable neutralizing activity in the IM + ID immunized animals. These results demonstrated that DNA immunization can be used to generate an immune response against a B virus glycoprotein in uninfected macaques.

Original languageEnglish (US)
Pages (from-to)4865-4873
Number of pages9
JournalVaccine
Volume19
Issue number32
DOIs
StatePublished - Sep 14 2001

Fingerprint

Macacine herpesvirus 1
Cercopithecine Herpesvirus 1
DNA Vaccines
Macaca
recombinant vaccines
Macaca mulatta
immune response
glycoproteins
Glycoproteins
mice
Immunization
immunization
Secondary Immunization
antibodies
Antibodies
Virus Diseases
neutralization
animals
plasmids
Plasmids

Keywords

  • B virus
  • Cercopithecine herpesvirus 1
  • DNA vaccination
  • Macaca mulatta

ASJC Scopus subject areas

  • Immunology
  • Microbiology
  • Virology
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)

Cite this

Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques. / Loomis-Huff, Jennifer E.; Eberle, R.; Lockridge, Kristen M.; Rhodes, Gary; Barry, Peter A.

In: Vaccine, Vol. 19, No. 32, 14.09.2001, p. 4865-4873.

Research output: Contribution to journalArticle

Loomis-Huff, Jennifer E. ; Eberle, R. ; Lockridge, Kristen M. ; Rhodes, Gary ; Barry, Peter A. / Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques. In: Vaccine. 2001 ; Vol. 19, No. 32. pp. 4865-4873.
@article{fa2d960160e34250adf97aa55c4c4b52,
title = "Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques",
abstract = "Herpes B virus (Cercopithecine herpesvirus 1) is endemic in captive macaque populations and poses a serious threat to humans who work with macaques or their tissues. A vaccine that could prevent or limit B virus infection in macaques would lessen occupational risk. To that end, a DNA vaccine plasmid expressing the B virus glycoprotein B (gB) was constructed and tested for immunogenicity in mice and macaques. Intramuscular (IM) or intradermal (ID) immunization in mice elicited antibodies to gB that were relatively stable over time and predominately of the IgG2a isotype. Five juvenile macaques were immunized by either IM + ID (n = 2) or IM (n = 3) routes, with two booster immunizations at 10 and 30 weeks. All five animals developed antibodies to B virus gB, with detectable neutralizing activity in the IM + ID immunized animals. These results demonstrated that DNA immunization can be used to generate an immune response against a B virus glycoprotein in uninfected macaques.",
keywords = "B virus, Cercopithecine herpesvirus 1, DNA vaccination, Macaca mulatta",
author = "Loomis-Huff, {Jennifer E.} and R. Eberle and Lockridge, {Kristen M.} and Gary Rhodes and Barry, {Peter A}",
year = "2001",
month = "9",
day = "14",
doi = "10.1016/S0264-410X(01)00232-8",
language = "English (US)",
volume = "19",
pages = "4865--4873",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "32",

}

TY - JOUR

T1 - Immunogenicity of a DNA vaccine against herpes B virus in mice and rhesus macaques

AU - Loomis-Huff, Jennifer E.

AU - Eberle, R.

AU - Lockridge, Kristen M.

AU - Rhodes, Gary

AU - Barry, Peter A

PY - 2001/9/14

Y1 - 2001/9/14

N2 - Herpes B virus (Cercopithecine herpesvirus 1) is endemic in captive macaque populations and poses a serious threat to humans who work with macaques or their tissues. A vaccine that could prevent or limit B virus infection in macaques would lessen occupational risk. To that end, a DNA vaccine plasmid expressing the B virus glycoprotein B (gB) was constructed and tested for immunogenicity in mice and macaques. Intramuscular (IM) or intradermal (ID) immunization in mice elicited antibodies to gB that were relatively stable over time and predominately of the IgG2a isotype. Five juvenile macaques were immunized by either IM + ID (n = 2) or IM (n = 3) routes, with two booster immunizations at 10 and 30 weeks. All five animals developed antibodies to B virus gB, with detectable neutralizing activity in the IM + ID immunized animals. These results demonstrated that DNA immunization can be used to generate an immune response against a B virus glycoprotein in uninfected macaques.

AB - Herpes B virus (Cercopithecine herpesvirus 1) is endemic in captive macaque populations and poses a serious threat to humans who work with macaques or their tissues. A vaccine that could prevent or limit B virus infection in macaques would lessen occupational risk. To that end, a DNA vaccine plasmid expressing the B virus glycoprotein B (gB) was constructed and tested for immunogenicity in mice and macaques. Intramuscular (IM) or intradermal (ID) immunization in mice elicited antibodies to gB that were relatively stable over time and predominately of the IgG2a isotype. Five juvenile macaques were immunized by either IM + ID (n = 2) or IM (n = 3) routes, with two booster immunizations at 10 and 30 weeks. All five animals developed antibodies to B virus gB, with detectable neutralizing activity in the IM + ID immunized animals. These results demonstrated that DNA immunization can be used to generate an immune response against a B virus glycoprotein in uninfected macaques.

KW - B virus

KW - Cercopithecine herpesvirus 1

KW - DNA vaccination

KW - Macaca mulatta

UR - http://www.scopus.com/inward/record.url?scp=0035860627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035860627&partnerID=8YFLogxK

U2 - 10.1016/S0264-410X(01)00232-8

DO - 10.1016/S0264-410X(01)00232-8

M3 - Article

C2 - 11535340

AN - SCOPUS:0035860627

VL - 19

SP - 4865

EP - 4873

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 32

ER -